AKBA
Akebia Therapeutics Inc.
Company Overview
| Mkt Cap | $819.30M | Price | $2.21 |
| Volume | 6.11M | Change | +5.24% |
| P/E Ratio | -11.8 | Open | $2.11 |
| Revenue | $160.2M | Prev Close | $2.10 |
| Net Income | $-69.4M | 52W Range | $1.52 - $4.08 |
| Div Yield | N/A | Target | $7.40 |
| Overall | 28 | Value | 20 |
| Quality | -- | Technical | 36 |
No chart data available
Stock Overview
Updated DailyAkebia Therapeutics Inc. (AKBA) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.21 with a market capitalization of $819.30 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AKBA with a volume of 6.11 million shares. The stock opened up 0.48% from yesterday's close of $2.10. Current analyst estimates project earnings of $0.03 per share for this year, with next year targeting $0.23.
AKBA demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including AMGN, NVS, JNJ, NKTR, ENZN.
Key investment considerations for AKBA include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 234.8%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:53 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $2.21 | +5.2% | 6.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW